Immuneering Retained Earnings from 2010 to 2025

IMRX Stock  USD 1.94  0.03  1.57%   
Immuneering Corp Retained Earnings yearly trend continues to be fairly stable with very little volatility. Retained Earnings are likely to outpace its year average in 2025. Retained Earnings is the cumulative amount of net income that Immuneering Corp retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals
 
Retained Earnings  
First Reported
2010-12-31
Previous Quarter
-146.9 M
Current Value
-139.6 M
Quarterly Volatility
58.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Immuneering Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immuneering Corp's main balance sheet or income statement drivers, such as Net Interest Income of 4.1 M, Interest Income of 4.1 M or Depreciation And Amortization of 425.1 K, as well as many indicators such as Price To Sales Ratio of 207, Dividend Yield of 0.0 or PTB Ratio of 2.18. Immuneering financial statements analysis is a perfect complement when working with Immuneering Corp Valuation or Volatility modules.
  
Check out the analysis of Immuneering Corp Correlation against competitors.
For more information on how to buy Immuneering Stock please use our How to Invest in Immuneering Corp guide.

Latest Immuneering Corp's Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Immuneering Corp over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Immuneering Corp's Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immuneering Corp's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (163.26 M)10 Years Trend
Slightly volatile
   Retained Earnings   
       Timeline  

Immuneering Retained Earnings Regression Statistics

Arithmetic Mean(45,722,049)
Geometric Mean20,961,872
Coefficient Of Variation(127.86)
Mean Deviation48,778,435
Median(8,697,742)
Standard Deviation58,460,365
Sample Variance3417.6T
Range154.6M
R-Value(0.82)
Mean Square Error1226.3T
R-Squared0.67
Significance0.0001
Slope(10,014,090)
Total Sum of Squares51264.2T

Immuneering Retained Earnings History

2025-139.6 M
2024-146.9 M
2023-163.3 M
2022-109.8 M
2021-59.3 M
2020-25.7 M

Other Fundumenentals of Immuneering Corp

Immuneering Corp Retained Earnings component correlations

0.980.97-0.96-0.810.85-0.49-0.380.981.00.941.00.940.870.930.51-0.59-0.39
0.980.99-0.9-0.80.8-0.59-0.541.00.980.950.980.950.830.930.5-0.58-0.35
0.970.99-0.9-0.820.81-0.61-0.550.990.970.970.960.970.860.940.53-0.6-0.34
-0.96-0.9-0.90.84-0.920.420.17-0.9-0.96-0.9-0.96-0.9-0.92-0.92-0.480.620.4
-0.81-0.8-0.820.84-0.890.750.36-0.8-0.79-0.92-0.77-0.92-0.93-0.92-0.730.90.61
0.850.80.81-0.92-0.89-0.55-0.160.80.840.880.820.880.970.940.59-0.7-0.41
-0.49-0.59-0.610.420.75-0.550.79-0.59-0.47-0.69-0.45-0.69-0.56-0.73-0.620.750.52
-0.38-0.54-0.550.170.36-0.160.79-0.54-0.36-0.49-0.36-0.49-0.22-0.47-0.270.310.15
0.981.00.99-0.9-0.80.8-0.59-0.540.980.950.980.950.830.930.5-0.58-0.35
1.00.980.97-0.96-0.790.84-0.47-0.360.980.931.00.930.860.920.49-0.58-0.38
0.940.950.97-0.9-0.920.88-0.69-0.490.950.930.911.00.940.970.66-0.74-0.43
1.00.980.96-0.96-0.770.82-0.45-0.360.981.00.910.910.840.910.48-0.56-0.37
0.940.950.97-0.9-0.920.88-0.69-0.490.950.931.00.910.940.970.66-0.74-0.43
0.870.830.86-0.92-0.930.97-0.56-0.220.830.860.940.840.940.940.65-0.73-0.4
0.930.930.94-0.92-0.920.94-0.73-0.470.930.920.970.910.970.940.64-0.75-0.48
0.510.50.53-0.48-0.730.59-0.62-0.270.50.490.660.480.660.650.64-0.91-0.83
-0.59-0.58-0.60.620.9-0.70.750.31-0.58-0.58-0.74-0.56-0.74-0.73-0.75-0.910.87
-0.39-0.35-0.340.40.61-0.410.520.15-0.35-0.38-0.43-0.37-0.43-0.4-0.48-0.830.87
Click cells to compare fundamentals

About Immuneering Corp Financial Statements

Immuneering Corp investors use historical fundamental indicators, such as Immuneering Corp's Retained Earnings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immuneering Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Retained Earnings-146.9 M-139.6 M
Retained Earnings Total Equity-98.8 M-103.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immuneering Stock Analysis

When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.